1 results match your criteria: "Universidad de Cantabria and Valdecilla Biomedical Research Institute (IDIVAL)[Affiliation]"
Migraine treatment: quo vadis? Real-world data study (2015-2022) in Spain.
BMC Neurol
April 2024
Service of Neurology, University Hospital Marqués de Valdecilla, Universidad de Cantabria and Valdecilla Biomedical Research Institute (IDIVAL), Santander, Cantabria, Spain.
Background: Migraine is a leading cause of disability, estimated to affect one-in-ten people in Spain. This study aimed to describe the management of migraine in Spain and identify improvement areas.
Methods: Non-interventional, retrospective, cross-sectional cohort study conducted using an electronic medical records database covering visits to public healthcare providers for 3% of the Spanish population.